Grünenthal GmbH: Pain trials
The registry lists 19 Pain studies with Grünenthal GmbH as lead sponsor. 1 are open to participants now and 11 have results posted.
Phase 1 6Phase 2 4Phase 3 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A First-in-human Trial of GRT7041 in Healthy ParticipantsRecruitingNCT07289776Phase 1
- A Study to Look at Tapentadol Tablets in Children and Adolescents in PainCompletedNCT02151682Phase 2/3Results posted
- Intravenous Tapentadol in Post-Bunionectomy PainCompletedNCT01435577Phase 2Results posted
- Tapentadol in Chronic Malignant Tumour Related PainTerminatedNCT01264887Phase 3Results posted
- A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983YTerminatedNCT01056315Phase 2Results posted
- Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of TolerabilityTerminatedNCT00986258Phase 3Results posted
- Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular AnalgesicsCompletedNCT00983385Phase 3Results posted
- Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking Either WHO Step I or Step II Analgesics or no Regular AnalgesicCompletedNCT00983073Phase 3Results posted
- A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After BunionectomyCompletedNCT00609466Phase 3Results posted
- A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and MorphineTerminatedNCT00505414Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the KneeCompletedNCT00486811Phase 3Results posted
- A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and MorphineCompletedNCT00472303Phase 3Results posted
- Clinical Pilot Study in Healthy Men to Characterize the Uptake of Buprenorphine Into and Its Elimination From the Body After Topical Application of Two New Forms of a Skin Patch in Comparison to a Reference PatchCompletedNCT03785613Phase 1
- Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 HoursCompletedNCT03770234Phase 1
- A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure Which Aims to Evaluate Whether GRT0151Y is Likely to be AbusedCompletedNCT03768024Phase 1
- A Clinical Study in Healthy Women Which Aims to Explore the Intestinal Uptake of Two Different Tablets of GRTA9906 Into the Body and the Effect of Food on itCompletedNCT03765801Phase 1
- A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure to Investigate the Safety and Tolerability of GRT0151Y and to Find Out Which Single Dose of the Compound is Maximally ToleratedCompletedNCT03765658Phase 1
- Efficacy and Tolerability of Lidocaine Plaster for Treatment of Long-term Local Nerve PainCompletedNCT01752322Phase 3
- Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative PainTerminatedNCT01155986Phase 2